Companies/Avitar, Inc.

Company profile

Avitar, Inc.

OTC: AVTI · Healthcare · Medical - Specialties

Canadian filerHQ Calgary, MAReports USD

#738 of 1,394 Healthcare companies by revenuebottom-quartile growth

EA Score

——

FH —DQ —GM —SS 48

v0.1 · 5/100 weight · pillars only

↑ operating margin, listing tenure · ↓ market scale, balance-sheet leverage

Methodology →

Revenue TTM

$2.7M

Rev growth YoY (TTM)

-47.4%

Net income (FY)

-$2.3M

Employees

Market cap

$1.4k

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$3.1M$3.1M2007

Net income-$2.3M-$2.3M2007

Operating income$2.7M$2.7M2007

Total assets$1.7M$1.7M2007

Liabilities$11.6M$11.6M2007

Equity-$9.8M-$9.8M2007

Revenue trend

FY2000 – FY2007 · USD

$4.1M

FY00

$6.5M

FY01

$9.6M

FY02

$4.6M

FY03

$4.0M

FY04

$4.5M

FY05

$4.9M

FY06

$3.1M

FY07

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

Avitar, Inc. booked $3.1M in FY2007 revenue, contracting 37% year over year — slower than 78% of Healthcare companies we track, at a -72.7% net margin.

Peers · Healthcare

Oracle Healthcare Acquisition Corp.——Wildflower Brands Inc.——Applied Biosciences Corp.——Evolutionary Genomics, Inc.——

Key facts

CEOCory H. Gelmon

SectorHealthcare

IndustryMedical - Specialties

HeadquartersCalgary, MA

ExchangeOTC: AVTI

Employees36

IPO date1994-10-31

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.